Eric Arvidson, MD
Orthopaedic Surgery · Salem, NHNPI 1689666547
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Smith+Nephew at 44.6% of the total. Reporting peaked in 2024 at $2,507 and has fallen 84.5% since, to $389 in 2025.
Across 56 payments — averaging $87.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Stryker$1K
- Zimmer Biomet$540
- Johnson & Johnson$174
- Ferring Pharmaceuticals Inc.$107
- Bioventus LLC$78
- plus $377 from 12 others
What the payments were for
- Travel & lodging$2,60953%
- Food & beverage$2,30147%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 11 | $2,191 |
| Stryker | 10 | $1,443 |
| Zimmer Biomet | 4 | $540 |
| Johnson & Johnson(2 entities) | 6 | $174 |
| Ferring Pharmaceuticals Inc. | 5 | $107 |
| Bioventus LLC | 3 | $78 |
| Novartis | 3 | $64 |
| Endo USA, Inc. | 2 | $58 |
| Endo Pharmaceuticals Inc. | 2 | $49 |
| Fidia Pharma USA Inc. | 2 | $40 |
| Pacira Pharmaceuticals Incorporated | 1 | $31 |
| Organon | 1 | $27 |
| Amgen | 1 | $24 |
| Sandoz | 1 | $20 |
| Kairos Surgical Inc | 1 | $17 |
| Vertex | 1 | $16 |
| Nalu Medical, Inc. | 1 | $15 |
| Convatec Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$2,641
- Legion Revision$1,151
- OR3O Dual Mobility$1,151
- RI.HIP NAVIGATION$1,151
- JOURNEY$1,151
- MAKO$1,121
- Persona$299
- Avenir$129
- INSIGNIA$121
- Persona Revision$112
How this compares
$4,910 in reported general payments places this provider in the 65th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 161 | $337 |
| Diclofenac Sodium | 29 | $317 |
| Celecoxib | 27 | $258 |
| Sulindac | 26 | $215 |
| Cephalexin | 69 | $196 |
| Mupirocin | 12 | $100 |
| Methylprednisolone | 13 | $95 |
| Oxycodone Hcl | 17 | $60 |
| Gabapentin | 11 | $60 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Salem
- Jay MottlaSalem$16K
- Thomas HoernerSalem$13K
- Tahsin ErginSalem$5K
- Akhilesh SastryPortsmouth$966K
- Mayo NoerdlingerPortsmouth$529K
- John-Erik BellLebanon$528K
- Michael MorwoodPortsmouth$506K
- Ira ParsonsSomersworth$245K
- Alexander OremLebanon$215K
- David RichardsNashua$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.